Shell Pharmaceuticals Private Limited

Shell Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2009PTC449217 Incorporated 05 August 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹16.43 Cr
▲ 16% YoY
Net loss · FY 2022
₹40.7 Lakh
Net margin -2.5%
EBITDA · FY 2022
-₹34.1 Lakh
EBITDA margin -2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Open charges
₹35 Cr
Satisfied ₹51.45 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
2
Provident fund records

About Shell Pharmaceuticals Private Limited

Data last updated:

Shell Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ascent Health And Wellness Solutions Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 August 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2009PTC449217. Its GSTIN is 33AANCS3235R1ZS (Tamil Nadu).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Srinivasa Ramanathan Manickam and Praveen Mishra.

Its last annual general meeting (AGM) was held on 03 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2022, the company reported a revenue of ₹16.43 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹40.7 Lakh (net margin -2.5%) and EBITDA of -₹34.1 Lakh (EBITDA margin -2.1%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 14% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹35 Cr and satisfied charges of ₹51.45 Cr on record. The company has 3 deals on record (3 secondary share transfers); the latest was in June 2019.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shellpharmaceuticals.com.

Company details

CIN U51909MH2009PTC449217
Registration Number 449217
Incorporation Date 05 August 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 03 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Ascent Health And Wellness Solutions Private Limited
Compliance Status Active Compliant

CIN history

Shell Pharmaceuticals has one previous CIN (Corporate Identification Number): U51909TN2009PTC072476. The current CIN is U51909MH2009PTC449217, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909MH2009PTC449217Current
U51909TN2009PTC072476Previous

Contact details

Shell Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    B – 3 And B 7 1st Flr Krishna Mill Compound, Sonapur Lane Lbs Marg, Mumbai, Maharashtra, India – 400078
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Shell Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Shell Pharmaceuticals Private Limited

FY 2025 filings available

Shell Pharmaceuticals Private Limited reported revenue of ₹16.43 Cr (up 16% YoY) for FY 2022.

Revenue · FY 2022
₹16.43 Cr ▲ 16%
Net loss · FY 2022
₹40.7 Lakh margin -2.5%
EBITDA · FY 2022
-₹34.1 Lakh margin -2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 12%
5 years · compounded
▼ 14%

Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹16.43 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹34.1 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹40.7 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin-2.1%
Net Profit Margin-2.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shell Pharmaceuticals Private Limited, buy the company report.

Board of directors of Shell Pharmaceuticals Private Limited

Shell Pharmaceuticals has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Srinivasa Ramanathan ManickamDirector27 Feb 20233 Years 7 MonthsCurrent
Rajaganesan RajbalajiAdditional Director16 Dec 20250 Years 10 MonthsCurrent
Praveen MishraDirector11 Sep 20242 Years 1 MonthsCurrent
Darshan Anil HariaAdditional Director01 Apr 20251 Years 6 MonthsCurrent
Harshal Ashok ChaudhariDirector20 Aug 20251 Years 2 MonthsCurrent

Charges & borrowings

Open charges
₹35 Cr
Satisfied charges
₹51.45 Cr
Breakdown by lending institutions
Axis Bank Limited₹35.00 Cr
Others₹7.20 Cr
Hdfc Bank Limited₹6.50 Cr
The Hongkong and Shanghai Banking Corporation Limited₹2.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Oct 2019100298101Axis Bank Limited₹35 CrSatisfied
21 Nov 2017100156425Others₹7.2 CrSatisfied
11 Jul 2017100120580Hdfc Bank Limited₹4.5 CrSatisfied
01 Mar 201610623447The Hongkong and Shanghai Banking Corporation Limited₹2.75 CrSatisfied
16 Feb 201510565084Hdfc Bank Limited₹2 CrSatisfied

To see the full charge records of Shell Pharmaceuticals Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Shell Pharmaceuticals Private Limited has 3 deals on record (3 secondary share transfers); the latest was in June 2019.

Total deals
3
Secondary share transfers
3

Deals on record (3 of 3)

WhenDealAmountParties
Jun 2019Secondary share transferUndisclosedBuyer: Siddharth Shah & Ascent Health and Wellness Solutions Private Limited, Ascent Helath and Wellness Solutions Private Limited
Seller: 2 individuals
Oct 2016Secondary share transferUndisclosedBuyer: Ascent Helath and Wellness Solutions Private Limited
Seller: 2 individuals
Mar 2014Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Shell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Shell Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AANCS3235R1ZSTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Shell Pharmaceuticals Private Limited, buy the company report.

Recent activity

Shell Pharmaceuticals Private Limited has 17 board changes on record since 2013: 5 appointments and 12 cessations. The latest: Rajaganesan Rajbalaji was appointed as Additional Director on 16 Dec 2025.

Appointed
Rajaganesan Rajbalaji was appointed as Additional Director.
AGM
Shell Pharmaceuticals Private Limited last Annual general meeting of members was held on 03 Sep 2025 as per latest MCA records.
Ceased
Darshan Anil Haria ceased to be Additional Director.
Ceased
Harshal Ashok Chaudhari ceased to be Additional Director.
Appointed
Harshal Ashok Chaudhari was appointed as Director.
Appointed
Darshan Anil Haria was appointed as Additional Director.
Filing
Shell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 09 Oct 2019 via Charge ID 100298101 with Axis Bank Limited was fully satisfied on 18 Mar 2025.
Ceased
Praveen Mishra ceased to be Additional Director.
Ceased
Varun Harikishan Mehta ceased to be Additional Director.
Appointed
Praveen Mishra was appointed as Director.
Ceased
Srinivasa Ramanathan Manickam ceased to be Additional Director.

18 earlier events are in the company report.

Frequently asked questions

Shell Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 August 2009 (17+ years old) and is registered under CIN U51909MH2009PTC449217.

Shell Pharmaceuticals has 5 current directors:

The latest financial statements of Shell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 03 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Shell Pharmaceuticals is 33AANCS3235R1ZS, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Shell Pharmaceuticals is U51909MH2009PTC449217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shell Pharmaceuticals was incorporated on 05 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.

Shell Pharmaceuticals has 3 deals on record (3 secondary share transfers); the latest was in June 2019.

Rajaganesan Rajbalaji was appointed as Additional Director on 16 Dec 2025. Darshan Anil Haria ceased to be Additional Director on 02 Sep 2025. Harshal Ashok Chaudhari ceased to be Additional Director on 02 Sep 2025. Shell Pharmaceuticals has 17 board changes on record in total.

Shell Pharmaceuticals can be reached through the website shellpharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Shell Pharmaceuticals is at B – 3 And B 7 1st Flr Krishna Mill Compound, Sonapur Lane Lbs Marg, Mumbai, Maharashtra, India – 400078.